Jeffrey M Rothschild
Biographic Data
| ID | 5545617 |
|---|---|
| NAME | Jeffrey M Rothschild |
| GIVEN NAMES | Jeffrey M |
| FAMILY NAME | Rothschild |
| SIGNATURE | ROTHSCHILD J M |
| AFFILIATIONS | Brigham and Women's Hospital |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2008 |
| H-INDEX | 0 |
Costs of Intravenous Adverse Drug Events in Academic and Nonacademic Intensive Care Units
BACKGROUND: Adverse drug events (ADEs), particularly those involving intravenous medications (IV-ADEs), are common among intensive care unit (ICU) patients and may increase hospitalization costs. Precise cost estimates have not been reported for academic ICUs, and no studies have included nonacademic ICUs. OBJECTIVES: To estimate increases in costs and length of stay after IV-ADEs at an academic and a nonacademic hospital. RESEARCH DESIGN: This s…
Hospital Workload and Adverse Events
CONTEXT: Hospitals are under pressure to increase revenue and lower costs, and at the same time, they face dramatic variation in clinical demand. OBJECTIVE: : We sought to determine the relationship between peak hospital workload and rates of adverse events (AEs). METHODS: A random sample of 24,676 adult patients discharged from the medical/surgical services at 4 US hospitals (2 urban and 2 suburban teaching hospitals) from October 2000 to Septem…
No prominent works on this page.
Hospital Workload and Adverse Events
CONTEXT: Hospitals are under pressure to increase revenue and lower costs, and at the same time, they face dramatic variation in clinical demand. OBJECTIVE: : We sought to determine the relationship between peak hospital workload and rates of adverse events (AEs). METHODS: A random sample of 24,676 adult patients discharged from the medical/surgical services at 4 US hospitals (2 urban and 2 suburban teaching hospitals) from October 2000 to Septem…
Costs of Intravenous Adverse Drug Events in Academic and Nonacademic Intensive Care Units
BACKGROUND: Adverse drug events (ADEs), particularly those involving intravenous medications (IV-ADEs), are common among intensive care unit (ICU) patients and may increase hospitalization costs. Precise cost estimates have not been reported for academic ICUs, and no studies have included nonacademic ICUs. OBJECTIVES: To estimate increases in costs and length of stay after IV-ADEs at an academic and a nonacademic hospital. RESEARCH DESIGN: This s…
Adverse effect (2 works) · Emergency Medicine (2 works) · Emergency Medicine (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Patient Safety and Medication Errors (2 works) · Context (archaeology) (1 work) · Environmental health (1 work) · Intensive care (1 work)